UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

International journal of molecular sciences, 2021-12, Vol.23 (1), p.4

2021

Volltextzugriff (PDF)

Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer

The Prostate, 2017-04, Vol.77 (5), p.479-488

2017

Volltextzugriff (PDF)

Eyelid metastasis in non-small-cell lung cancer: diagnosis and management

The American journal of medicine, 2016-09, Vol.129 (9), p.e169-e172

2016

Volltextzugriff (PDF)

Teleoncology for Veterans: High Patient Satisfaction Coupled With Positive Financial and Environmental Impacts

JCO oncology practice, 2021-09, Vol.17 (9), p.e1362-e1374

2021

Volltextzugriff (PDF)

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma

Frontiers in oncology, 2022-09, Vol.12, p.855794-855794

2022

Volltextzugriff (PDF)

Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2018-08, Vol.32 (4), p.311-317

2018

Volltextzugriff (PDF)

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

Frontiers in oncology, 2020-08, Vol.10, p.1112-1112

2020

Volltextzugriff (PDF)

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria

Cancer, 2014-12, Vol.120 (24), p.3853-3858

2014

Volltextzugriff (PDF)

Implementation of a Multidisciplinary Care Pathway via an Emergency Department-ICU to Improve Care of Emergency Department Patients Presenting With Leukostasis

Critical care explorations, 2020-02, Vol.2 (2), p.e0084-e0084

2020

Volltextzugriff (PDF)

Bevacizumab in Advanced NSCLC: Chemotherapy Partners and Duration of Use

Current treatment options in oncology, 2013-12, Vol.14 (4), p.595-609

2013

Volltextzugriff (PDF)

Indoleamine 2,3.Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2018-08, Vol.32 (4), p.311-317

2018

Volltextzugriff (PDF)

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports

Clinical diabetes and endocrinology, 2019-01, Vol.5 (1), p.1-1, Article 1

2019

Volltextzugriff (PDF)

Assessment of patient satisfaction, financial, and environmental impacts of teleoncology

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.278-278

2021

Volltextzugriff (PDF)

Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma

Ophthalmic plastic and reconstructive surgery, 2023-09, Vol.39 (5), p.e152-e155

2023

Volltextzugriff (PDF)

Increased incidence of immune-mediated myocarditis in advanced skin malignancies treated with immune checkpoint inhibitors in the COVID-19 era

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2664-2664

2022

Volltextzugriff (PDF)

Toxicities with combination BRAF and MEK inhibition in resected stage III melanoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e22086-e22086

2020

Volltextzugriff (PDF)

Immunotherapy for mucosal melanoma

Annals of translational medicine, 2019-07, Vol.7 (S3), p.S118-S118

2019

Volltextzugriff (PDF)

BIOMARKER TRENDS AND OUTCOMES IN PATIENTS RECEIVING IMMUNE-CHECKPOINT INHIBITORS

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.2366-2366

2023

Volltextzugriff (PDF)

Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era

Cancer Immunology, Immunotherapy : CII, 2024-10, Vol.73 (12), p.259, Article 259

2024

Volltextzugriff (PDF)

Abstract 12324: Biomarker Trends in Patients With Immune-Checkpoint Inhibitor Myocarditis

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

1271: IMPROVEMENTS IN CARE OF LEUKEMIC CRISIS AFTER INSTITUTION OF AN EDICU AND MULTIDISCIPLINARY PATHWAY

Critical care medicine, 2019-01, Vol.47 (1), p.612-612

2019

Volltextzugriff (PDF)

Abstract 13185: Incidence and Risk Factors of Acute Cardiovascular Complications After Hematopoietic Stem Cell Transplantation

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2022-01, Vol.163, p.35-41

2022

Volltextzugriff (PDF)

A Jaw‐Dropping Diagnosis

Journal of hospital medicine, 2020-11, Vol.15 (11), p.687-691

2020

Volltextzugriff (PDF)

Focal radiation with pulsed systemic therapy of abiraterone, androgen deprivation therapy (ADT), olaparib towards castration-sensitive oligometastatic prostate cancer (FAALCON Trial)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS5113-TPS5113

2022

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(11)
Oncology
(11)
Biomarkers
(5)
Immunotherapy
(5)
Male
(5)
Melanoma
(5)
Cancer Therapies
(4)
Metastasis
(4)
Aged
(3)
Carcinoma, Non-Small-Cell Lung - Therapy
(3)
Clinical Trials
(3)
Female
(3)
Immune Checkpoint Inhibitors
(3)
Lung Neoplasms - Pathology
(3)
Medical Prognosis
(3)
Prognosis
(3)
Toxicity
(3)
Animals
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer

Eyelid metastasis in non-small-cell lung cancer: diagnosis and management

Teleoncology for Veterans: High Patient Satisfaction Coupled With Positive Financial and Environmental Impacts

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma

Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria

Implementation of a Multidisciplinary Care Pathway via an Emergency Department-ICU to Improve Care of Emergency Department Patients Presenting With Leukostasis

Bevacizumab in Advanced NSCLC: Chemotherapy Partners and Duration of Use

Indoleamine 2,3.Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports

Assessment of patient satisfaction, financial, and environmental impacts of teleoncology

Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma

Increased incidence of immune-mediated myocarditis in advanced skin malignancies treated with immune checkpoint inhibitors in the COVID-19 era

Toxicities with combination BRAF and MEK inhibition in resected stage III melanoma

Immunotherapy for mucosal melanoma

BIOMARKER TRENDS AND OUTCOMES IN PATIENTS RECEIVING IMMUNE-CHECKPOINT INHIBITORS

Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era

Abstract 12324: Biomarker Trends in Patients With Immune-Checkpoint Inhibitor Myocarditis

1271: IMPROVEMENTS IN CARE OF LEUKEMIC CRISIS AFTER INSTITUTION OF AN EDICU AND MULTIDISCIPLINARY PATHWAY

Abstract 13185: Incidence and Risk Factors of Acute Cardiovascular Complications After Hematopoietic Stem Cell Transplantation

Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer

A Jaw‐Dropping Diagnosis

Focal radiation with pulsed systemic therapy of abiraterone, androgen deprivation therapy (ADT), olaparib towards castration-sensitive oligometastatic prostate cancer (FAALCON Trial)

Suchergebnisse filtern